Larger volumes can cause discomfort or poor absorption
PlexusDx also offers GLP-Squared, a dual-compound injection combining semaglutide and tirzepatide in one vial, at $289/mo month-to-month, or from $249/mo on the 6-month plan for patients seeking combined pathway activation
Furthermore, studies have shown GLP-1RAs are associated with a modest decrease in intraocular pressure, particularly in individuals with elevated baseline intraocular pressure (IOP) [103], and a reduced risk of developing glaucoma in patients with T2DM [104]
Current cardiovascular guidance recognizes apolipoprotein B, lipoprotein(a), hs-CRP, and elevated triglycerides as markers that may help refine a persons atherosclerotic cardiovascular risk
Both the European Medicines Agency and the World Health Organization last year issued product alerts for semaglutide and a potential increased risk of NAION